Total current assets 11,312 7,245
Property and equipment, net 554 912
------------- -------------
TOTAL ASSETS $ 11,866 $ 8,157
------------- -------------
------------- -------------
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities:
Current liabilities:
Accounts payable and accrued liabilities $ 886 $ 1,878
Deferred revenue 2,500 3,377
Other current liabilities - 170
------------- -------------
Total current liabilities 3,386 5,425
Deferred revenue - non-current 6,667 4,951
Other non-current liabilities - 373
------------- -------------
Total liabilities 10,053 10,749
------------- -------------
Stockholders' Equity (Deficit):
Convertible preferred stock 192 192
Common stock 63 66
Additional paid-in capital 14,620 14,207
Accumulated other comprehensive income 12 23
Accumulated deficit during development stage (13,074) (17,080)
------------- -------------
Total stockholders' equity (deficit) 1,813
'/>"/>
| SOURCE NovaBay Pharmaceuticals, Inc. Copyright©2007 PR Newswire. All rights reserved |